Curcumin inhibits hyperlipidemia and hepatic fat accumulation in high-fructose-fed male Wistar rats

References

• Ahima RS, Saper CB, Flier JS, Elmquist JK. 2000. Leptin regulation of neuroendocrine systems. Front Neuroendocrinol. 21:263–307.
   PubMed Web of Science ®Google Scholar
• Anitha Nandhini AT, Balakrishnan SD, Anuradha CV. 2002. Taurine improves lipid profile in rats fed a high fructose-diet. Nutr Res. 22:343–354.
   Web of Science ®Google Scholar
• Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ. 1998. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem. 273:5678–5684.
   PubMed Web of Science ®Google Scholar
• Bantle JP, Raatz SK, Thomas W, Georgopoulos A. 2000. Effects of dietary fructose on plasma lipids in healthy subjects. Am J Clin Nutr. 72:1128–1134.
   PubMed Web of Science ®Google Scholar
• Bengmark S. 2006. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. J Parenter Enteral Nutr. 30:45–51.
   PubMed Web of Science ®Google Scholar
• Bray GA, Nielsen SJ, Popkin BM. 2004. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 79:537–543.
   PubMed Web of Science ®Google Scholar
• Brunzell JD. 2007. Clinical practice. Hypertriglyceridemia. N Engl J Med. 357:1009–1017.
   PubMed Web of Science ®Google Scholar
• Chen G, Liang G, Ou J, Goldstein JL, Brown MS. 2004. Central role for liver X receptor in insulin-mediated activation of SREBP-1c transcription and stimulation of fatty acid synthesis in liver. Proc Natl Acad Sci USA. 101:11245–11250.
   PubMed Web of Science ®Google Scholar
• Chypre M, Zaidi N, Smans K. 2012. ATP-citrate lyase: a mini-review. Biochem Biophys Res Commun. 422:1–4.
   PubMed Web of Science ®Google Scholar
• Dobiásová M. 2006. AIP – atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice. Vnitr˘ Ní Lékar˘ Ství. 52:64–71.
   PubMedGoogle Scholar
• Dobiásová M, Frohlich J. 2000. The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy. Vnitr˘ Ní Lékar˘ Ství. 46:152–156.
   PubMedGoogle Scholar
• Folch J, Lees M, Sloane Stanley GH. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 226:497–509.
   PubMed Web of Science ®Google Scholar
• Grefhorst A, Elzinga BM, Voshol PJ, Plösch T, Kok T, Bloks VW, van der Sluijs FH, Havekes LM, Romijn JA, Verkade HJ et al. 2002. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J Biol Chem. 277:34182–34190.
   PubMed Web of Science ®Google Scholar
• Huang YJ, Fang VS, Juan CC, Chou YC, Kwok CF, Ho LT. 1997. Amelioration of insulin resistance and hypertension in a fructose-fed rat model with fish oil supplementation. Metab Clin Exp. 46:1252–1258.
   PubMed Web of Science ®Google Scholar
• Hwang IS, Ho H, Hoffman BB, Reaven GM. 1987. Fructose-induced insulin resistance and hypertension in rats. Hypertension. 10:512–516.
   PubMed Web of Science ®Google Scholar
• Jang E-M, Choi M-S, Jung UJ, Kim MJ, Kim HJ, Jeon SM, Shin SK, Seong CN, Lee MK. 2008. Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters. Metab Clin Exp. 57:1576–1583.
   PubMed Web of Science ®Google Scholar
• Joseph SB, Laffitte BA, Patel PH, Watson MA, Matsukuma KE, Walczak R, Collins JL, Osborne TF, Tontonoz P. 2002. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem. 277:11019–11025.
   PubMed Web of Science ®Google Scholar
• Kim HY, Okubo T, Juneja LR, Yokozawa T. 2010. The protective role of amla (Emblica officinalis Gaertn.) against fructose-induced metabolic syndrome in a rat model. Br J Nutr. 103:502–512.
   PubMed Web of Science ®Google Scholar
• Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680–685.
   PubMed Web of Science ®Google Scholar
• Leone TC, Weinheimer CJ, Kelly DP. 1999. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA. 96:7473–7478.
   PubMed Web of Science ®Google Scholar
• Li J-M, Li Y-C, Kong L-D, Hu Q-H. 2010. Curcumin inhibits hepatic protein-tyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose-fed rats. Hepatology (Baltim MD). 51:1555–1566.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:265–275.
   PubMed Web of Science ®Google Scholar
• Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. 2001. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 50:1844–1850.
   PubMed Web of Science ®Google Scholar
• Mayes PA. 1993. Intermediary metabolism of fructose. Am J Clin Nutr. 58:754S–765S.
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Dobrzyn A, Man WC, Chu K, Sampath H, Kim HJ, Ntambi JM. 2004. Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and independent mechanisms. J Biol Chem. 279:25164–25171.
   PubMed Web of Science ®Google Scholar
• Na L-X, Zhang Y-L, Li Y, Liu LY, Li R, Kong T, Sun CH. 2011. Curcumin improves insulin resistance in skeletal muscle of rats. Nutr Metab Cardiovasc Dis. 21:526–533.
   PubMed Web of Science ®Google Scholar
• Neuschwander-Tetri BA, Caldwell SH. 2003. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. 37:1202–1219.
   PubMed Web of Science ®Google Scholar
• Park OJ, Cesar D, Faix D, Wu K, Shackleton CH, Hellerstein MK. 1992. Mechanisms of fructose-induced hypertriglyceridaemia in the rat. Activation of hepatic pyruvate dehydrogenase through inhibition of pyruvate dehydrogenase kinase. Biochem J. 282:753–757.
   PubMed Web of Science ®Google Scholar
• Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, Shan B, Brown MS, Goldstein JL, Mangelsdorf DJ. 2000. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXR-alpha and LXR-beta. Genes Dev. 14:2819–2830.
   PubMed Web of Science ®Google Scholar
• Shao W, Yu Z, Chiang Y, Yang Y, Chai T, Foltz W, Lu H, Fantus IG, Jin T. 2012. Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS One. 7:e28784.
   PubMed Web of Science ®Google Scholar
• Shapiro A, Mu W, Roncal C, Cheng KY, Johnson RJ, Scarpace PJ. 2008. Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am J Physiol Regul Integr Comp Physiol. 295:1370–1375.
   PubMed Web of Science ®Google Scholar
• Shapiro H, Bruck R. 2005. Therapeutic potential of curcumin in non-alcoholic steatohepatitis. Nutr Res Rev. 18:212–221.
   PubMed Web of Science ®Google Scholar
• Shimano H, Yahagi N, Amemiya-Kudo M, Hasty AH, Osuga J, Tamura Y, Shionoiri F, Iizuka Y, Ohashi K, Harada K, et al. 1999. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem. 274:35832–35839.
   PubMed Web of Science ®Google Scholar
• Sikder K, Das N, Kesh SB, Dey S. 2014. Quercetin and beta-sitosterol prevent high fat diet induced dyslipidemia and hepatotoxicity in Swiss albino mice. Indian J Exp Biol. 52:60–66.
   PubMed Web of Science ®Google Scholar
• Simmons RK, Alberti KG, Gale EA, Colagiuri S, Tuomilehto J, Qiao Q, Ramachandran A, Tajima N, Brajkovich Mirchov I, Ben-Nakhi A, et al. 2010. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia. 53:600–605.
   PubMed Web of Science ®Google Scholar
• Tang Y, Zheng S, Chen A. 2009. Curcumin eliminatesleptin's effects on hepatic stellate cell activation via interrupting leptin signaling. Endocrinology. 150:3011–3020.
   PubMed Web of Science ®Google Scholar
• Tappy L, Lê K-A. 2010. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 90:23–46.
   PubMed Web of Science ®Google Scholar
• Um MY, Hwang KH, Ahn J, Ha TY. 2013. Curcumin attenuates diet-induced hepatic steatosis by activating AMP-activated protein kinase. Basic Clin Pharmacol Toxicol. 113:152–157.
   PubMed Web of Science ®Google Scholar
• Yokozawa T, Kim HJ, Cho EJ. 2008. Gravinol ameliorates high-fructose-induced metabolic syndrome through regulation of lipid metabolism and pro-inflammatory state in rats. J Agric Food Chem. 56:5026–5032.
   PubMed Web of Science ®Google Scholar
• Yudkin J. 1967. Evolutionary and historical changes in dietary carbohydrates. Am J Clin Nutr. 20:108–115.
   PubMed Web of Science ®Google Scholar
• Zhao C, Dahlman-Wright K. 2010. Liver X receptor in cholesterol metabolism. J Endocrinol. 204:233–240.
   PubMed Web of Science ®Google Scholar
• Zhao J, Sun X-B, Ye F, Tian W-X. 2011. Suppression of fatty acid synthase, differentiation and lipid accumulation in adipocytes by curcumin. Mol Cell Biochem. 351:19–28.
   PubMed Web of Science ®Google Scholar